Insomnia as a predictor of recurrent cardiovascular events in patients with coronary heart disease.

ABSTRACT:

Study objectives

Insomnia is highly prevalent in patients with coronary heart disease (CHD). However, the potential effect of insomnia on the risk of recurrent major adverse cardiovascular events (MACE) remains uncertain.

Methods

This prospective cohort study included 1082 consecutive patients 2-36 (mean 16) months after myocardial infarction and/or coronary revascularization. Data on clinical insomnia, coronary risk factors, and comorbidity were collected at baseline. Clinical insomnia was assessed using the Bergen Insomnia Scale (BIS). The primary composite endpoint of MACE (cardiovascular death, hospitalization due to myocardial infarction, revascularization, stroke, or heart failure) was assessed with an average follow-up of 4.2 (SD 0.3) years after baseline. Data were a

SUBMITTER: Frojd LA 

PROVIDER: S-EPMC10104412 | biostudies-literature | 2022

REPOSITORIES: biostudies-literature